These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 31963118)
1. Modeling Challenges of Ebola Virus-Host Dynamics during Infection and Treatment. Chertow DS; Shekhtman L; Lurie Y; Davey RT; Heller T; Dahari H Viruses; 2020 Jan; 12(1):. PubMed ID: 31963118 [TBL] [Abstract][Full Text] [Related]
2. Modelling Ebola virus dynamics: Implications for therapy. Martyushev A; Nakaoka S; Sato K; Noda T; Iwami S Antiviral Res; 2016 Nov; 135():62-73. PubMed ID: 27743917 [TBL] [Abstract][Full Text] [Related]
3. A review on the antagonist Ebola: A prophylactic approach. Khan FN; Qazi S; Tanveer K; Raza K Biomed Pharmacother; 2017 Dec; 96():1513-1526. PubMed ID: 29208326 [TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Therapeutic Approaches Against Ebola Virus Infection. Soni M; Tulsian K; Barot P; Vyas VK Recent Adv Antiinfect Drug Discov; 2024; 19(4):276-299. PubMed ID: 38279760 [TBL] [Abstract][Full Text] [Related]
5. Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease. Bird BH; Spengler JR; Chakrabarti AK; Khristova ML; Sealy TK; Coleman-McCray JD; Martin BE; Dodd KA; Goldsmith CS; Sanders J; Zaki SR; Nichol ST; Spiropoulou CF J Infect Dis; 2016 Mar; 213(5):703-11. PubMed ID: 26582961 [TBL] [Abstract][Full Text] [Related]
6. Host Factors Involved in Ebola Virus Replication. Rasmussen AL Curr Top Microbiol Immunol; 2018; 419():113-150. PubMed ID: 28710692 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Review on Ebola (EBOV) Virus: Future Prospects. Khan S; Muhammad ; Rauf A; Khan A; Rizwan M; Patel S; Khan H; Mahasneh AM; Mubarak MS Infect Disord Drug Targets; 2018; 18(2):96-104. PubMed ID: 28820067 [TBL] [Abstract][Full Text] [Related]
8. Comparative Transcriptomics Highlights the Role of the Activator Protein 1 Transcription Factor in the Host Response to Ebolavirus. Wynne JW; Todd S; Boyd V; Tachedjian M; Klein R; Shiell B; Dearnley M; McAuley AJ; Woon AP; Purcell AW; Marsh GA; Baker ML J Virol; 2017 Dec; 91(23):. PubMed ID: 28931675 [No Abstract] [Full Text] [Related]
9. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells. Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347 [TBL] [Abstract][Full Text] [Related]
10. Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga. Chiramel AI; Banadyga L; Dougherty JD; Falzarano D; Martellaro C; Brees D; Taylor RT; Ebihara H; Best SM J Infect Dis; 2016 Oct; 214(suppl 3):S355-S359. PubMed ID: 27511894 [TBL] [Abstract][Full Text] [Related]
12. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit. Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682 [TBL] [Abstract][Full Text] [Related]
13. Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo. Herbert AS; Davidson C; Kuehne AI; Bakken R; Braigen SZ; Gunn KE; Whelan SP; Brummelkamp TR; Twenhafel NA; Chandran K; Walkley SU; Dye JM mBio; 2015 May; 6(3):e00565-15. PubMed ID: 26015498 [TBL] [Abstract][Full Text] [Related]
14. A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus. Flint M; Chatterjee P; Lin DL; McMullan LK; Shrivastava-Ranjan P; Bergeron É; Lo MK; Welch SR; Nichol ST; Tai AW; Spiropoulou CF Nat Commun; 2019 Jan; 10(1):285. PubMed ID: 30655525 [TBL] [Abstract][Full Text] [Related]
15. Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques. Jankeel A; Menicucci AR; Woolsey C; Fenton KA; Mendoza N; Versteeg K; Cross RW; Geisbert TW; Messaoudi I J Virol; 2020 May; 94(11):. PubMed ID: 32213610 [TBL] [Abstract][Full Text] [Related]
16. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system. Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038 [TBL] [Abstract][Full Text] [Related]
17. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection. Kroeker A; Griffin BD; Qiu X; Kobinger G Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628 [TBL] [Abstract][Full Text] [Related]